Alphamab Oncology (FRA:3NK)
0.9600
0.00 (0.00%)
At close: Jan 27, 2026
Alphamab Oncology Employees
Alphamab Oncology had 484 employees as of June 30, 2025.
Employees
484
Change
n/a
Growth
n/a
Revenue / Employee
€193,017
Profits / Employee
€57,175
Market Cap
930.10M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 484 | - | - |
| Dec 31, 2024 | 420 | -15 | -3.45% |
| Dec 31, 2023 | 435 | -37 | -7.84% |
| Dec 31, 2022 | 472 | 13 | 2.83% |
| Dec 31, 2021 | 459 | 125 | 37.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Paul Hartmann AG | 10,082 |
| Gelsenwasser AG | 1,898 |
| FRoSTA Aktiengesellschaft | 1,760 |
| Maschinenfabrik Berthold Hermle AG | 1,607 |
| Südwestdeutsche Salzwerke AG | 1,186 |
| EUROKAI GmbH & Co. KGaA | 950 |
| tonies SE | 567 |
| Northern Data AG | 199 |